Instant steam takes on MRSAJuly 30, 2007A method for making instant steam, without the need for electricity, promises to be useful for tackling antibiotic resistant 'superbugs' like MRSA and C. difficile, as well as removing chewing gum from pavements and powering environmentally friendly cars, reports Nina Morgan in Chemistry & Industry, the magazine of the SCI. 'The value of instant steam lies in creating truly portable steam that can be generated intermittently on demand,' says Dave Wardle, business development director at Oxford Catalysts. The company is already in talks with UK specialist steam supplier OspreyDeepclean about possible applications for steam cleaning hospitals, Wardle adds. An as-yet unpublished 2006 study at University College London Hospital, commissioned by OspreyDeepclean, showed that dry steam applied at temperatures ranging from 150 to 180 C could destroy bacteria, including MRSA and Clostridium difficile, in less than two seconds, without the use of chemicals. The new technology, devised by scientists at UK firm Oxford Catalysts, employs a precious metal catalyst to generate the steam at temperatures up to 800 C in just a couple of seconds, at room temperature and pressure. Steam produced by the technology is so-called 'dry' steam, generated by the highly exothermic reaction between methanol and hydrogen peroxide. While too expensive to replace the vast quantities of steam used routinely by industry, a reaction chamber the size of a sugar cube can pump steam at a rate of 7L/minute at temperatures up to 800 C.
The first application is likely to be a GumBuster backpack for removing chewing gum from pavements and other surfaces. The patented GumBuster technology currently requires a minimum of 3kW of electrical power to generate the steam used by each operator and relies on generators carried on trolleys or vans. Use of the catalyst technology 'will make the system more portable and make it possible to place the steam when we need it, where we need it,' says Thomas Stuecken, chief commercial officer at Proventec, the parent company of OspreyDeepclean. Other more speculative applications for the steam for powering rockets and cars, and to provide mobile and portable power generation, are currently being considered. Society of Chemical Industry | |||||||||||||||||||||
|
Related MRSA Current Events and MRSA News Articles Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Rhode Island Hospital study finds local retail meat safe from antibiotic-resistant organisms Rhode Island Hospital researchers report that findings from a new study of retail meat in the Providence, RI area indicate little to no presence of antibiotic-resistant bacteria. Researchers downplay MRSA screening as effective infection control intervention Three Virginia Commonwealth University epidemiologists are downplaying the value of mandatory universal nasal screening of patients for MRSA, arguing that proven, hospital-wide infection control practices can prevent more of the potentially fatal infections. Nanotechnology boosts war on superbugs This week Nature Nanotechnology journal (October 12th) reveals how scientists from the London Centre for Nanotechnology (LCN) at UCL are using a novel nanomechanical approach to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as MRSA. Is re-emerging superbug the next MRSA? Loyola physicians warn little-known bacteria Clostridium difficile next emerging disease threat, killing 1,000s in the United State. University of Virginia Study Reveals Promising Method for Reducing MRSA Infections in Hospital Intensive Care Units Doctors at the University of Virginia Health System have significantly reduced MRSA infections among surgical intensive care patients by using antibiotic cycling, a method of rotating drugs at regular intervals. 'Superbug' breast infections controllable in nursing mothers, researchers find Many nursing mothers who have been hospitalized for breast abscesses are afflicted with the "superbug" methicillin-resistant Staphylococcus aureus, or MRSA, but according to new research by UT Southwestern Medical Center physicians, conservative treatment can deal with the problem. Nature inspires new highly specific drugs and organic products The best place to seek novel compounds for pharmaceutical drugs, alternative energy sources, and a host of industrial applications, is within natural systems that have evolved over millions of years. Chips are down as Manchester makes protein scanning breakthrough Scientists at The University of Manchester have developed a new and fast method for making biological 'chips' - technology that could lead to quick testing for serious diseases, fast detection of MRSA infections and rapid discovery of new drugs. Researchers analyze how new anti-MRSA abtibiotics function A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA. More MRSA Current Events and MRSA News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||